WEB REGISTRATION CLOSES:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center Leendert van ven BosChief Executive Officer at EnzyTag BVSpeaker
Profile
Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. He joined Organon BioSciences as a Scientist in 2007 and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. End of 2018, he co-founded EnzyTag and serves as CEO since then. Leendert holds an Executive MBA from Nyenrode University. In 2022, he co-founded the biotech start-up GlycoTheraperutics focusing on developing carbohydrate-based molecules that serve as new checkpoint
Agenda Sessions
Fragment-based Approaches for Acylated Peptide Synthesis; An Analysis of Cost and Capacity
, 4:15pmView Session